Publications & Resources

Recent Publications from the Center (Since 2010):

Clinical Care

Lai C-H, Melli G, Chang Y-J, Skolasky RL, Corse AM, Wagner KR, Cornblath DR. Open muscle biopsy in suspected myopathy:  diagnostic yield and clinical utility. Eur J Neurol, 17:136-142, 2010. PMID: 19674068

Bushby K, and the DMD Care Considerations Working Group. The Diagnosis and Management of Duchenne Muscular Dystrophy—Part 1. Diagnosis, Pharmacological and Psychological Management. Lancet Neurology, 9: 77-93, 2010. PMID: 19945913

Bushby K, and the DMD Care Considerations Working Group. The Diagnosis and Management of Duchenne Muscular Dystrophy—Part 2. Implementation of Multidisciplinary Care. Lancet Neurlogy, 9: 177-189, 2010.  PMID: 19945914

Jangouk P and Wagner KR. Muscular Dystrophy and the Family. In Encyclopedia of Family Health. Eds Craft-Rosenberg M and Pehler, SR. 2: 743-745, 2011.

Sparks SE and Escolar DM. Congenital muscular dystrophies. Handbook of Clinical Neurology 101: 47-79, 2011.

Leung D, Germaine-Lee E, Denger B and Wagner KR. Report on the Second Endocrine Aspects of Duchenne Muscular Dystrophy Conference. Neuromuscular Disorders, 21(8): 594-601, 2011. PMID: 21763136

Judge DP, Kass DA, Thompson WR, Wagner KR. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. Am J Cardiovasc Drugs 11(5): 387-294, 2011. PMID: 21812510

Clinical Research

Wagner KR.  Clinical Applications of Myostatin Inhibitors for Neuromuscular Diseases. Immun., Endoc &Metab. Agents in Med. Chem. 20: 204-210, 2010.

The Muscle Study Group. A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol, 70(3): 427-436, 2011. PMID: 21688301

Zimmerman A, Clemens PR, Tesi-Rocha C, Connolly A, Iannaccone ST, Kuntz N, Arrieta A, Hache L, Henricson E, Hu F, Mayhew J, Escolar DM. Liquid formulation of pentoxifylline is a poorly tolerated treatment for duchenne dystrophy. Muscle Nerve. 2011 Aug;44(2):170-3. PMID: 21674534

Nazarian S, Bluemke DA, Wagner KR, Zviman MM, Turkbey E, Caffo BS, Shehata M, Edwards D, Butcher B, Calkins H, Berger RD, Halperin HR, Tomaselli GF. QRS Prolongation in Myotonic Muscular Dystrophy and Diffuse Fibrosis on Cardiac Magnetic Resonance. Magn Reson Med, 64: 107-114, 2010. PMID: 20572151

Spurney CF, Rocha CT, Henricson E, Florence J, Mayhew J, Gorni K, Pasquali L, Pestronk A, Martin GR, Hu F, Nie L, Connolly AM, Escolar DM CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve. 2011 Aug;44(2):174-8. PMID: 21698649

Nazarian S, Wagner KR, Caffo BS, Tomaselli GF. Clinical Predictors of Conduction Disease Progression in Type 1 Myotonic Muscular Dystrophy. Pacing Clin Electrophysiol, 34:171-176, 2011. PMID: 20946286

Escolar DM, Hache LP, Clemens PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AJ, Bertorini TE, Nevo Y, Lotze T, Pestronk A, Ryan MM, Monasterio E, Day JW, Zimmerman A, Arrieta A, Henricson E, Mayhew J, Florence J, Hu F, Connolly AM. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology. 2011 Aug 2;77(5):444-52. Epub 2011 Jul 13. PMID: 21753160

Turkbey EB, Gai N, Lima JA, van der Geest RJ, Wagner KR, Tomaselli GF, Bluemke DA, Nazarian S. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on Magnetic Resonance Imaging. Heart Rhythm 2012. In Press. PMID: 22710483

Escolar DM, Zimmerman A, Bertorini T, Clemens PR, Connolly AM, Mesa L, Gorni K, Kornberg A, Kolski H, Kuntz N, Nevo Y, Tesi-Rocha C, Nagaraju K, Rayavarapu S, Hache LP, Mayhew JE, Florence J, Hu F, Arrieta A, Henricson E, Leshner RT, Mah JK. Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial. Neurology. 2012 Mar 20;78(12):904-13. PMID: 22402864

Laboratory Research

Rahimov F, King OD, Warsing LC, Powell RE, Emerson CP, Kunkel LM, Wagner KR. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor. Physiol Genomics 43: 398-407, 2011. PMID: 21266502

Stadler G, Chen J, Wagner KR, Robin JD, Shay JW, Emerson CP Jr, Wright WE. Establishment of clonal myogenic cell lines from severely affected dystrophic muscles—CDK4 maintains the myogenic population. Skeletal Muscle. 1:12, 2011.

Greenberg SA, Salajegheh M, Judge DP, Feldman MW, Kuncl RW, Waldon Z, Steen H, Wagner KR. Etiology of limb girdle muscular dystrophy 1D/1E determined by laser capture microdissection proteomics. Ann Neurol. 71(1):  141-145, 2012. PMID:22275259

Kornegay JN, Childers MK, Boan DJ, Bogan JR, Nghiem P, Wang J, Fan Z, Howard JF Jr, Schatzberg SJ, Dow JL, Grange RW, Styner MA, Hoffman EP, Wagner KR. The paradox of muscle hypertrophy in muscular dystrophy.  Phys Med Rehabil Clin N Am 23(1): 149-172, 2012. PMID: 22239881

Li ZB, Zhang J, Wagner KR. Inhibiting myostatin reverses muscle fibrosis through apoptosis. J Cell Sci 2012. In press. PMID: 22685331

Additional Resources:

The Center for Genetic Muscle Disorders has compiled a list of helpful related resources as a service to our users. These links are intended to be used for informational purposes only.